Indivior CEO and CFO receive base salary increases effective Jan 1, 2026

Indivior Pharmaceuticals, Inc.

CEO Joseph Ciaffoni salary increased from $1,050,000 to $1,115,000.
CFO Ryan Preblick salary increased from $559,000 to $604,000.
Changes effective January 1, 2026, approved by Board on Dec 12, 2025.
Based on competitive market review and Compensation Committee recommendation.

item 5.02

Indivior Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001625297-25-000076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.